Table 6.
CET (n=7) | SIT (n=8) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||
Week No | M ± SD | Δ% | p | D | Week No | M ± SD | Δ% | p | d | |
WBC (103/µL) | W0 | 7.92 ± 2.35 | −2.1 | 0.758 | −0.078 | W0 | 6.91 ± 1.53 | 9.7 | 0.321 | 0.506 |
W7 | 7.75 ± 2.02 | W7 | 7.58 ± 1.08 | |||||||
CRP (mg/L) | W0 | 4.39 ± 2.76 | −26.2 | 0.312 | −0.589 | W0 | 3.27 ± 0.24 | 9.8 | 0.475 | 0.388 |
W7 | 3.24 ± 0.13 | W7 | 3.59 ± 1.14 | |||||||
AST (U/L) | W0 | 15.9 ± 4.81 | 0.0 | 1.000 | 0.000 | W0 | 17.4 ± 4.37 | 12.9 | 0.227 | 0.489 |
W7 | 15.9 ± 2.41 | W7 | 19.6 ± 4.78 | |||||||
ALT (U/L) | W0 | 11.1 ± 2.79 | 15.4 | 0.373 | 0.652 | W0 | 16.4 ± 8.95 | 34.3 | 0.018* | 0.741 |
W7 | 12.9 ± 2.48 | W7 | 22.0 ± 5.92ǂ | |||||||
CK (U/L) | W0 | 132 ± 61.1 | 11.5 | 0.743 | 0.217 | W0 | 134 ± 40.3 | 31.1 | 0.447 | 0.378 |
W7 | 147 ± 77.4 | W7 | 175 ± 150 | |||||||
CK-MB (U/L) | W0 | 13.5 ± 5.17 | 12.9 | 0.557 | 0.327 | W0 | 12.8 ± 4.46 | 20.0 | 0.320 | 0.639 |
W7 | 15.3 ± 5.53 | W7 | 15.4 ± 3.53 | |||||||
cTnI (ng/mL) | W0 | 0.031 ± 0.079 | 16.1 | 0.078 | 0.062 | W0 | 0.000 ± 0.000 | 0.3 | 0.170 | 0.849 |
W7 | 0.036 ± 0.081 | W7 | 0.003 ± 0.005 |
p=0.002 (statistically significantly higher compared with data of CET), CET: continuous endurance training, SIT: sprint interval training, WBC: white blood cell, CRP: C-reactive protein, AST: aspartate aminotransferase, ALT: alanine aminotransferase, CK: creatine kinase, CK-MB: creatine kinase-myocardial band, cTnI: cardiac troponin I, M: mean, SD: standard deviation, Δ%: percentage change in means, d: Cohen’s d (<0.2 trivial; 0.2 ≤ d < 0.5 small; 0.5 ≤ d ≤ 0.8 moderate; d > 0.8 large effect size), W: week